Gyre Therapeutics Inc. (GYRE)
NASDAQ · Healthcare
Gyre Therapeutics Inc. EPS 2009–2025
Gyre Therapeutics Inc. annual/quarterly eps history and growth rate from 2009 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Gyre Therapeutics Inc. eps for the quarter ending March 31, 2026 was $0.10.
- Gyre Therapeutics Inc. annual eps for 2025 was $0.02, a 60.00% decrease from 2024.
- Gyre Therapeutics Inc. annual eps for 2024 was $0.05, a 103.55% decrease from 2023.
- Gyre Therapeutics Inc. annual eps for 2023 was $1.41, a 4800.00% decrease from 2022.
- Gyre Therapeutics Inc. annual eps for 2022 was $0.03.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Gyre Therapeutics Inc. EPS — FAQ
Gyre Therapeutics Inc. (GYRE) eps over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Gyre Therapeutics Inc.'s eps?
Gyre Therapeutics Inc. (GYRE) reported eps of $0.02 for fiscal 2025.
Where can I see GYRE's eps history?
The chart and table above show Gyre Therapeutics Inc.'s eps by year and by quarter, including the growth rate.